1′S-1′-acetoxychavicol acetate isolated from Alpinia galanga inhibits human immunodeficiency virus type 1 replication by blocking Rev transport

Journal of General Virology

Volumn 87, Issue 7, 2006, Pages 2047-2053

  Ye, Ying ^a,b,c   Li, Baoan ^b  

^a Department of Research and Development   (China)

^b XIAMEN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOXYCHAVICOL ACETATE; ALPINIA GALANGA EXTRACT; ANTIVIRUS AGENT; DIDANOSINE; REV PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; ZIDOVUDINE; 1' ACETOXYCHAVICOL ACETATE; 1'-ACETOXYCHAVICOL ACETATE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PLANT EXTRACT; TERPENE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SEPARATION TECHNIQUE; VIRUS REPLICATION; ACTIVE TRANSPORT; ALPINIA; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; ISOLATION AND PURIFICATION; METABOLISM; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PHYTOTHERAPY; VIROLOGY;

ALPINIA GALANGA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ACTIVE TRANSPORT, CELL NUCLEUS; ALPINIA; ANTI-HIV AGENTS; BASE SEQUENCE; CELL LINE; DRUG EVALUATION, PRECLINICAL; GENE PRODUCTS, REV; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; PHYTOTHERAPY; PLANT EXTRACTS; RNA, VIRAL; TERPENES; VIRUS REPLICATION;

EID: 33745635020     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81685-0     Document Type: Article

References (38)

1. Ando, S., Matsuda, H., Morikawa, T. & Yoshikawa, M. (2005). 1-pmS-1′-Acetoxychavicol acetate as a new type inhibitor of interferon-β production in lipopolysaccharide-activated mouse peritoneal macrophages. Bioorg Med Chem 13, 3289-3294.
2. Bevec, D., Dobrovnik, M., Hauber, J. & Böhnlein, E. (1992). Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc Natl Acad Sci U S A 89, 9870-9874.
3. Bevec, D., Jaksche, H., Oft, M. & 9 other authors (1996). Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 271, 1858-1860.
4. Biesert, L., Zimmermann, F., Schroder, B., Matthes, E., Suhartono, H., Dietrich, U. & Rubsamen-Waigmann, H. (1991). Biochemical and genetical analysis of AZT-resistant HIV-mutants. Behring Inst Mitt 89, 74-80.
5. De Pooter, H. L., Omar, M. N., Coolsaet, B. A. & Schamp, N. M. (1985). The essential oil of greater galanga (Alpinia galanga) from Malaysia. Phytochemistry 24, 93-96.
6. Duan, L., Bagasra, O., Laughlin, M. A., Oakes, J. W. & Pomerantz, R. J. (1994). Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc Natl Acad Sci U S A 91, 5075-5079.
7. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T. & Pavlakis, G. N. (1989). rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci U S A 86, 1495-1499.
8. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanassopoulos, A., Tse, A. & Pavlakis, G. N. (1989). The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J Virol 63, 1265-1274.
9. Janssen, A. M. & Scheffer, J. J. C. (1985). Acetoxyhydroxychavicol acetate, an antifungal component of Alpinia galanga. Planta Med 6, 507-511.
10. Kalland, K.-H., Szilvay, A. M., Brokstad, K. A., Sætrevik, W. & Haukenes, G. (1994). The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol Cell Biol 14, 7436-7444.
11. Kawabata, K., Tanaka, T., Yamamoto, T. & 7 other authors (2000). Suppression of N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis by dietary feeding of 1′-acetoxychavicol acetate. Jpn J Cancer Res 91, 148-155.
12. Kobayashi, Y., Nakae, D., Akai, H. & 9 other authors (1998). Prevention by 1′-acetoxychavicol acetate of the induction but not growth of putative preneoplastic, glutathione S-transferase placental form-positive, focal lesions in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Carcinogenesis 19, 1809-1814.
13. Kudo, N., Wolff, B., Sekimoto, T., Schreiner, E. P., Yoneda, Y., Yanagida, M., Horinouchi, S. & Yoshida, M. (1998). Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res 242, 540-547.
14. Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M. & Horinouchi, S. (1999). Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci U S A 96, 9112-9117.
15. Lee, T. C., Sullenger, B. A., Gallardo, H. F., Lingers, G. E. & Gilboa, E. (1992). Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol 4, 66-74.
16. Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V. & Cullen, B. R. (1989). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
17. Matsuda, H., Morikawa, T., Managi, H. & Yoshikawa, M. (2003). Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-α and IL-4 in RBL-2H3 cells. Bioorg Med Chem Lett 13, 3197-3202.
18. Matsukura, M., Zon, G., Shinozuka, K. & 7 other authors (1989). Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/ trs) in chronically infected cells. Proc Natl Acad Sci U S A 86, 4244-4248.
19. Menéndez-Arias, L. (2002). Targeting HIV: antiretroviral therapy and development of drug resistance. Trends Pharmacol Sci 23, 381-388.
20. Meyer, B. E. & Malim, M. H. (1994). The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev 8, 1538-1547.
21. Miyauchi, M., Nishikawa, A., Furukawa, F., Nakamura, H., Son, H.-Y., Murakami, A., Koshimizu, K., Ohigashi, H. & Hirose, M. (2000). Inhibitory effects of 1′-acetoxychavicol acetate on N-nitrosobis(2-oxopropyl)-amine-induced initiation of cholangiocarcinogenesis in Syrian hamsters. Jpn J Cancer Res 91, 477-481.
22. Morita, H. & Itokawa, H. (1988). Cytotoxic and antifungal diterpenes from the seeds of Alpinia galanga. Planta Med 54, 117-120.
23. Murakami, A., Ohura, S., Nakamura, Y., Koshimizu, K. & Ohigashi, H. (1996). 1′-Acetoxychavicol acetate, a superoxide anion generator inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in ICR mouse skin. Oncology 53, 386-391.
24. Murakami, N., Ye, Y., Kawanishi, M., Aoki, S., Kudo, N., Yoshida, M., Nakayama, E. E., Shioda, T. & Kobayashi, M. (2002). New Rev-transport inhibitor with anti-HIV activity from Valerianae radix. Bioorg Med Chem Lett 12, 2807-2810.
25. Najera, I., Richman, D. D., Olivares, I., Rojas, J. M., Peinado, M. A., Perucho, M., Najera, R. & López-Galindez, C. (1994). Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates. AIDS Res Hum Retroviruses 10, 1479-1488.
26. Ohnishi, M., Tanaka, T., Makita, H. & 7 other authors (1996). Chemopreventive effect of a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn J Cancer Res 87, 349-356.
27. Palittapongarnpim, P., Kirdmanee, C., Kittakoop, P. & Rukseree, K. (2002). 1′-Acetoxychavicol Acetate for Tuberculosis Treatment. US Patent Application no. 2002192262.
28. Pani, A., Loi, A. G., Mura, M., Marceddu, T., La Colla, P. & Marongiu, M. E. (2002). Targeting HIV: old and new players. Curr Drug Targets Infect Disord 2, 17-32.
29. Ratmeyer, L., Zapp, M. L., Green, M. R., Vinayak, R., Kumar, A., Boykin, D. W. & Wilson, W. D. (1996). Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives. Biochemistry 35, 13689-13696.
30. St Clair, M. H., Martin, J. L., Tudor-Williams, G., Bach, M. C., Vavro, C. L., King, D. M., Kellam, P., Kemp, S. D. & Larder, B. A. (1991). Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557-1559.
31. Tanaka, T., Kawabata, K., Kakumoto, M. & 8 other authors (1997a). Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate. Jpn J Cancer Res 88, 821-830.
32. Tanaka, T., Makita, H., Kawamori, T. & 7 other authors (1997b). A xanthine oxidase inhibitor 1′-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18, 1113-1118.
33. Tözsér, J. (2001). HIV inhibitors: problems and reality. Ann N Y Acad Sci 946, 145-159.
34. Witvrouw, M., van Maele, B., Vercammen, J., Hantson, A., Engelborghs, Y., de Clercq, E., Pannecouque, C. & Debyser, Z. (2004). Novel inhibitors of HIV-1 integration. Curr Drug Metab 5, 291-304.
35. Wolff, B., Sanglier, J. J. & Wang, Y. (1997). Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol 4, 139-147.
36. Yoshikawa, M., Matsuda, H. & Morikawa, T. (2004). Antiallergy agent obtained from Alpinia galanga and method for production thereof. Jpn Kokai Tokkyo Koho patent no. 2004189669 (in Japanese).
37. Zapp, M. L., Stern, S. & Green, M. R. (1993). Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74, 969-978.
38. Zapp, M. L., Young, D. W., Kumar, A., Singh, R., Boykin, D. W., Wilson, W. D. & Green, M. R. (1997). Modulation of the rev-RRE interaction by aromatic heterocyclic compounds. Bioorg Med Chem 5, 1149-1155.